Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
This page offers a quick comparison of Index Fund and Target Date for retirement, with tips on matching your plans and risk tolerance.
24,517 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Nvidia could be headed toward a $300 stock price as AI demand, margins, and strategic bets align. This article breaks...
Micron Technology reports a robust third quarter, beating expectations and raising guidance amid a fraught memory mar...
As 2025 closed, bank-owned homes grew rapidly, reshaping costs, timelines, and opportunities for buyers and investors...
A large block sale can shake a stock, but it isn’t a crush course in risk. This guide explains what investors should ...
A new Fed letter argues that higher unauthorized immigration during the Biden era helped expand the labor pool in key...
Better Home & Finance signs a tokenized funding deal with Framework Ventures to access up to $500 million in credit v...
Investors who have stacked some massive capital gains are weighing tax-efficient exit strategies as markets reach fre...
A major shift in ServiceNow's strategy, led by aggressive AI integration and larger enterprise contracts, could set t...
Visa and Bridge announce a global expansion of stablecoin-backed cards, moving from 18 markets to a planned 100 count...
When a gold stock soars 200%, even savvy investors reconsider risk. This article breaks down why trimming a large pos...
A 6% weekly pullback can feel painful, but for patient buyers, this growth stock march story is about resilience, rev...